The new study, part of the international Human Epilepsy Project, tracked nearly 150 adults who were deemed ...
12don MSN
Innovation in epilepsy care: Alternatives to medication seek to reset, repair brain, expert explains
Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...
News-Medical.Net on MSN
New study offers hope for patients with treatment-resistant focal epilepsy
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly ...
Hospital workers and public health officials say new combinations of street drugs, traumatic brain injuries and other health issues could be driving the uptick in seizures.
Medpage Today on MSN
Epilepsy Treatment Resistance May Fade Over Time
Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Focal treatment-resistant epilepsy ...
TipRanks on MSN
ONO Pharmaceutical’s Phase III Study on Cenobamate: A Potential Game-Changer for Epilepsy Treatment
ONO Pharmaceutical Co (($OPHLF)) announced an update on their ongoing clinical study. Study Overview: ONO Pharmaceutical Co. Ltd is conducting a ...
WASHINGTON -- U.S. health regulators have approved the first prescription drug made from marijuana, a milestone that could spur more research into a drug that remains illegal under federal law. The ...
Focal treatment-resistant epilepsy improves over time, but seizure reduction appears to be unrelated to specific medications ...
For the Oct. 7 advisory, the department looked at the number of drug use-related emergency department visits that involved a chief complaint or diagnosis of seizures from 2020 to 2025. It found a 110% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results